Adalimumab injection

( DrugBank: Adalimumab / KEGG DRUG: Adalimumab )

---

5 diseases

38. スティーヴンス・ジョンソン症候群

---

臨床試験数 : 19 / 薬物数 : 25 - (DrugBank : 10) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 98 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

40. 高安動脈炎

---

臨床試験数 : 30 / 薬物数 : 41 - (DrugBank : 22) / 標的遺伝子数 : 26 - 標的パスウェイ数 : 115 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

46. 悪性関節リウマチ

---

臨床試験数 : 4,543 / 薬物数 : 2,251 - (DrugBank : 390) / 標的遺伝子数 : 198 - 標的パスウェイ数 : 232 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

96. クローン病

---

臨床試験数 : 2,737 / 薬物数 : 1,197 - (DrugBank : 240) / 標的遺伝子数 : 182 - 標的パスウェイ数 : 221 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

162. 類天疱瘡（後天性表皮水疱症を含む。）

---

臨床試験数 : 128 / 薬物数 : 108 - (DrugBank : 49) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 143 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries